Current Assets
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value
MetLife AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value increased by 96.1% to $85.28B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 58.3%, from $53.86B to $85.28B. Over 5 years (FY 2020 to FY 2025), AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value shows an upward trend with a 9.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2020
Last reportedQ1 2026May 7, 2026
Metric ID:
afs_trading_securities_unrealized_loss_lt_12m_fvHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $40.48B | $50.71B | $62.02B | $125.18B | $174.50B | $179.17B | $165.46B | $95.29B | $62.45B | $60.42B | $26.35B | $31.69B | $40.10B | $18.15B | $59.81B | $53.86B | $48.64B | $38.16B | $43.50B | $85.28B |
| QoQ Change | — | +25.3% | +22.3% | +101.8% | +39.4% | +2.7% | -7.7% | -42.4% | -34.5% | -3.3% | -56.4% | +20.3% | +26.6% | -54.7% | +229.5% | -9.9% | -9.7% | -21.6% | +14.0% | +96.1% |
| YoY Change | — | — | — | — | +331.0% | +253.3% | +166.8% | -23.9% | -64.2% | -66.3% | -84.1% | -66.7% | -35.8% | -70.0% | +127.0% | +70.0% | +21.3% | +110.2% | -27.3% | +58.3% |
Range$18.15B – $179.17B
CAGR+17.0%
Avg YoY Growth+43.7%
Median YoY Growth-1.3%
Current Streak2 quarters growth
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value at Other Companies
Frequently Asked Questions
- What is MetLife's afs and trading securities - unrealized loss position (<12 months) fair value?
- MetLife (MET) reported afs and trading securities - unrealized loss position (<12 months) fair value of $85.28B in Q1 2026.
- How has MetLife's afs and trading securities - unrealized loss position (<12 months) fair value changed year-over-year?
- MetLife's afs and trading securities - unrealized loss position (<12 months) fair value increased by 58.3% year-over-year, from $53.86B to $85.28B.
- What is the long-term trend for MetLife's afs and trading securities - unrealized loss position (<12 months) fair value?
- Over 5 years (2020 to 2025), MetLife's afs and trading securities - unrealized loss position (<12 months) fair value has grown at a 9.4% compound annual growth rate (CAGR), from $27.73B to $43.50B.